Guardant Health
GH
#1451
Rank
S$19.49 B
Marketcap
S$146.99
Share price
17.09%
Change (1 day)
185.19%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Annual Reports (10-K)

Latest form 10-K annual reports for Guardant Health CIK: 0001576280

Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2026-02-19

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2025-02-20

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2024-02-22

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2023-02-23

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2022-02-24

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2021-02-25

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2020-03-02

Language: English

View Annual Report (10-K)
Thumbnail Guardant Health
 10-K Annual Report

10-K Annual Report 2019-03-19

Language: English

View Annual Report (10-K)